INTRODUCTION
During the past decade, the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is relatively selective for the dopaminergic (DA) nigro-striatal system, has attracted increasing attention. While MPTP's neurotoxic properties were discovered in humans /3,14/, it has been widely studied in other species.
In both human and non-human primates, MPTP can produce a tangible and persistent parkinsonianlike syndrome. This In the rhesus monkey, systemic injections produce a bilateral lesion of the nigro-striatal system /2/. When MPTP is injected into one internal carotid artery, the symptoms produced are largely those of hemi-parkinsonism /2/. This syndrome resembles the model induced by injection of 6-hydroxydopamine in the substantia nigra developed by Marshall and Ungerstedt /17/ in the rodent. In the rodent, one can make an in vivo assessment of the extent of the DA lesion by the intensity of spontaneous turning behavior, as well as the turning behavior induced by the administration of substances that stimulate the dopamine (DA) system such as apomorphine and amphetamine.
In this study, using 6-[SF]fluoro-L-3,4-dihydroxyphenylalanine (SF-DOPA) and xolabeled water with positron emission tomography (PET), we examined the pattern of distribution of SF-DOPA and cerebral blood flow (CBF) in the brains of rhesus monkeys after clinical recovery from unilateral MPTP treatment and compared the results with behavioral data. We discuss the model of Parkinson's disease induced by intra-arterial injection of MPTP in light of these data.
MATERIALS AND METHODS

Animal procedures
Eight naive male rhesus monkeys, rendered hemi-parkinsonian by MPTP injections into the internal carotid artery were used in this study. The animals' ages ranged from 3 to 14 years old ( Table  1 ). The age was obtained either from birth records, or from evaluation of the teeth and medical histories.
MFrP infusions
The method of MPTP administration was similar to that described by Bankiewicz et The data were stored in four sets of images corresponding to the injections at the four scanning levels. From the four sets of images, the slice where the basal ganglia was best represented was identified. In this slice, the striatum usually appears as a crescent that includes the head of the caudate nucleus and the dorsal part of the putamen (Fig. 1 slices of the anatomical set in the normal side of 7 of the 8 hemi-parkinsonian monkeys (Fig. 1) . In the oldest animal (M8), SF accumulation was apparent in only 3 slices. The contrast between specific and non-specific accumulation was also poorer in these slices than in comparable slices obtained from the younger animals. The loss of 8F accumulation from the non-injected side was also indicated by its lower RA value (Table 1 ).
There was a significantly lower 8F accumulation in the MPTP-lesioned striatum of the unilaterally treated animals compared to the nontreated side, normal controls and asymptomatic MPTP-treated monkeys (repeated measures ANOVA). There was no significant difference in striatal accumulation in the non-injected side compared with normal controls. The lSF accumulation in the posterior cortical areas and the surrounding muscles was similar in both sides and between the three groups.
As shown in Tables 1 and 3 and Fig. 2 , the striatum, putamen and caudate/cortex ratios on the MPTP-injected side were significantly lower than those of the non-treated side (p<0.01), and of normal control and clinically normal MPTP-treated animals (p<0.02). The striatum, putamen and caudate nucleus/cortex ratios in the non-injected side of the hemi-lesioned animals were not significantly different from normal controls ( Table  3) . The mean rate constant, K, for uptake of SF. DOPA from blood into striatum was significantly lower in the lesioned side of the unilaterally MPTP-treated animals compared with the noninjected side (p<0.0001) and normal control rhesus (p<0.0001) ( dose of MPTP, shows that the effects reported in acute and sub-chronic studies/12,21/are likely to remain even after the prolonged recovery period that has been found by others/13/.
The striatum, eaudate and putamen/ortex ratios of the MPTP-injeeted striatum are significantly lower than those of the normal controls and bilaterally MPTP-treated animals. In the bilaterally MPTP-treated monkeys, the caudate nucleus appeared less affected than the putamen (Fig. 2) /6/, but the caudate and putamen were equally affected in the hemi-parkinsonian preparation ( 
